Nifty Pharma index rises; Lupin, Cipla shares shine

NEW DELHI: Pharma shares were trading mixed with the Nifty Pharma index trading 0.2 per cent up at 9,663.1 around 12:12 pm on Monday.

Shares of Lupin (up 1.64 per cent), Cipla (up 1.24 per cent), Piramal Enterprises (up 1.03 per cent) and Cadila Healthcare (up 0.90 per cent) were among the top gainers in the index.

Biocon (down 1.67 per cent), Aurobindo Pharma (down 0.63 per cent), Glenmark Pharmaceuticals (down 0.63 per cent) and Sun Pharmaceutical Industries (down 0.14 per cent) were trading in the red.

Benchmark NSE Nifty50 index was down 9.40 points at 10,575.8 while BSE Sensex was down 79.56 points at 35,078.99 at that time.

Among the 50 stocks in the Nifty index, 21 were trading in the green, while 29 were in the red.

Shares of YES Bank, SBI, Tata Motors, Ashok Leyland, Titan Company, Bank of Baroda, ICICI Bank, Vedanta, HPCL and Cipla were among the most traded shares on the National Stock Exchange.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states